Biotech · Private company
Terremoto Biosciences Inc.
Track this companyFree. Adds Terremoto Biosciences Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Fulvestrant injectionPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- TER-2013Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- TER-1754Phase 1 · Hereditary Hemorrhagic Telangiectasia (HHT)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Trial of TER-1754 in Patients With Hereditary Hemorrhagic TelangiectasiaPHASE1 · WITHDRAWN · started Dec 15, 2025ClinicalTrials.gov NCT07255846 · fetched Nov 12, 2026
- A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsPHASE1_PHASE2 · RECRUITING · started Sep 23, 2025ClinicalTrials.gov NCT07109726 · fetched Nov 12, 2026